-+ 0.00%
-+ 0.00%
-+ 0.00%

ETON PHARMACEUTICALS - HOLDS EXCLUSIVE COMMERCIALIZATION RIGHTS FOR IMPAVIDO IN THE U.S.

Reuters·09/28/2026 10:50:01

Please log in to view news